Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $138.0400 (-1.27%) ($138.0400 - $138.0400) on Fri. Sep. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.94% (three month average) | RSI | 77 | Latest Price | $138.0400(-1.27%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 3.6% a day on average for past five trading days. | Weekly Trend | LGND advances 13.5% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) IWM(56%) IWC(53%) IWN(51%) | Factors Impacting LGND price | LGND will decline at least -1.47% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-16%) IGOV(-6%) UNG(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.47% (StdDev 2.94%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $134.09(2.95%) | 10 Day Moving Average | $124.81(10.6%) | 20 Day Moving Average | $116.26(18.73%) | To recent high | -1.3% | To recent low | 34.8% | Market Cap | $2.218b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |